Search Results - "Blemker, Gretchen"
-
1
Does Menopausal Status Affect Dry Eye Disease Treatment Outcomes with OC-01 (Varenicline Solution) Nasal Spray? A Post Hoc Analysis of ONSET-1 and ONSET-2 Clinical Trials
Published in Ophthalmology and therapy (01-02-2023)“…Introduction This study sought to compare the efficacy of OC-01 (varenicline solution) nasal spray for treatment of dry eye disease (DED) in postmenopausal…”
Get full text
Journal Article -
2
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
Published in Optometry and vision science (30-12-2022)Get full text
Journal Article -
3
OC-01
Published in Clinical ophthalmology (Auckland, N.Z.) (31-03-2023)“…Purpose: We evaluate the treatment effect of OC-01 (varenicline solution) nasal spray (VNS) in dry eye disease (DED) subjects from two randomized trials who…”
Get full text
Journal Article -
4
Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
Published in Optometry and vision science (01-02-2023)“…There is a clinical necessity for dry eye disease treatments that perform across a broad range of presenting patient severities. Varenicline solution nasal…”
Get full text
Journal Article -
5
OC-01
Published in Clinical ophthalmology (Auckland, N.Z.) (31-10-2022)“…Purpose: To evaluate OC-01 [varenicline solution nasal spray (VNS)] tear production and symptom outcomes in patients with dry eye disease by age, gender, race,…”
Get full text
Journal Article -
6
OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2
Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2023)“…We evaluate the treatment effect of OC-01 (varenicline solution) nasal spray (VNS) in dry eye disease (DED) subjects from two randomized trials who…”
Get full text
Journal Article -
7
OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use
Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2022)“…Purpose: To evaluate OC-01 [varenicline solution nasal spray (VNS)] tear production and symptom outcomes in patients with dry eye disease by age, gender, race,…”
Get full text
Journal Article